Quantbot Technologies LP Acquires 137,541 Shares of Doximity, Inc. $DOCS

Key Points

• Quantbot Technologies LP increased its stake in Doximity, Inc. by 182.6% during the 1st quarter, owning 212,868 shares valued at approximately $12.35 million.
• Doximity reported an earnings per share (EPS) of $0.36 for the last quarter, exceeding analysts' expectations of $0.31 and marking a 15.2% increase in quarterly revenue compared to the same period last year.
• Insider activity showed that directors sold a total of 36,000 shares valued at over $2.14 million in the past three months, indicating potential shifts in confidence among company leadership.

Quantbot Technologies LP lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 182.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 212,868 shares of the company's stock after acquiring an additional 137,541 shares during the period. Quantbot Technologies LP owned approximately 0.11% of Doximity worth $12,353,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. VSM Wealth Advisory LLC bought a new position in Doximity in the 1st quarter valued at approximately $29,000. Allworth Financial LP lifted its stake in Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares during the last quarter. National Bank of Canada FI bought a new position in Doximity in the 1st quarter valued at approximately $33,000. Spire Wealth Management lifted its stake in Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group raised its stake in shares of Doximity by 70.7% during the first quarter. Brooklyn Investment Group now owns 746 shares of the company's stock valued at $43,000 after acquiring an additional 309 shares during the last quarter. Institutional investors own 87.19% of the company's stock.

Doximity Stock Up 5.6%

DOCS traded up $3.5630 during midday trading on Friday, hitting $67.6930. The company had a trading volume of 1,637,248 shares, compared to its average volume of 2,323,116. Doximity, Inc. has a 52 week low of $35.32 and a 52 week high of $85.21. The company has a market capitalization of $12.68 billion, a price-to-earnings ratio of 67.69, a PEG ratio of 4.10 and a beta of 1.36. The stock's 50 day moving average price is $60.80 and its 200 day moving average price is $60.46.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the prior year, the company earned $0.28 earnings per share. The company's revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts predict that Doximity, Inc. will post 0.99 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on DOCS. Bank of America lifted their price target on shares of Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Zacks Research lowered shares of Doximity from a "strong-buy" rating to a "hold" rating in a report on Wednesday. Robert W. Baird cut their price target on shares of Doximity from $87.00 to $65.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Piper Sandler lifted their target price on shares of Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Finally, BTIG Research raised shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price for the company in a research note on Monday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $66.21.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director directly owned 6,360 shares of the company's stock, valued at $381,600. The trade was a 61.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director directly owned 16,618 shares of the company's stock, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 36,000 shares of company stock valued at $2,140,940 over the last three months. Corporate insiders own 31.30% of the company's stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.